SecBot SecBot
SECBOTREPLAY Home › Report › VIR

VIR · Vir Biotechnology's Chief Medical Officer, Mark Eisner, is stepping…

Vir Biotechnology, Inc. · 8-K filed Apr 10, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 10, 2026 at 16:01 ET

Vir Biotechnology's Chief Medical Officer, Mark Eisner, is stepping down effective April 24, 2026, and the company has begun a search for his successor. This is a C-suite departure but no immediate replacement was named.

  • Dr. Mark Eisner, Executive Vice President and Chief Medical Officer, is stepping down effective April 24, 2026.
  • He informed the company of his departure on April 7, 2026.
  • The company has initiated a search for a successor but has not named an interim or permanent replacement.
  • No reason for departure was specified beyond 'stepping down'.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access